Suchergebnisse - "O'Connor, Owen A"

PubPharm (151)

1

Pooled Analysis of Pralatrexate Single-Agent Studies in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma

enthalten in: Blood advances | 2024

von O'Connor, O. | Ko, B. | Wang, M. | +5

2

Mature T-cell and NK-cell lymphoma involvement of the central nervous system : a single center experience

enthalten in: Leukemia & lymphoma | 2023

von Ma, H. | Marchi, E. | O'Connor, O. | +1

3

Real-world experience of combined treatment with azacitidine and romidepsin in patients with peripheral T-cell lymphoma

enthalten in: Blood advances | 2023

von Kalac, M. | Jain, S. | Tam, C. | +7

4

HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models

enthalten in: Scientific reports | 2023

von Ke, H. | Zhang, F. | Wang, J. | +13

5

Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

enthalten in: Blood advances | 2022

von Savage, K. | Horwitz, S. | Advani, R. | +21

6

Inhibition of casein kinase 1δ disrupts translation initiation and exerts potent antilymphoma activity

enthalten in: Blood advances | 2022

von Pal, I. | Grilo, A. | Gaspary, A. | +6

7

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

enthalten in: Blood advances | 2021

von Davids, M. | O'Connor, O. | Jurczak, W. | +29

8

R-Loop-Mediated ssDNA Breaks Accumulate Following Short-Term Exposure to the HDAC Inhibitor Romidepsin

enthalten in: Molecular cancer research : MCR | 2021

von Safari, M. | Litman, T. | Robey, R. | +10

9

Targeting the T-Cell Lymphoma Epigenome Induces Cell Death, Cancer Testes Antigens, Immune-Modulatory Signaling Pathways

enthalten in: Molecular cancer therapeutics | 2021

von Scotto, L. | Kinahan, C. | Douglass, E. | +12

10

Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance

enthalten in: BMC cancer | 2021

von Oiwa, K. | Hosono, N. | Nishi, R. | +3

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[16]